S&P 500   3,435.56 (-0.22%)
DOW   28,210.82 (-0.35%)
QQQ   284.19 (-0.08%)
AAPL   116.87 (-0.54%)
MSFT   214.80 (+0.07%)
FB   278.73 (+4.17%)
GOOGL   1,585.99 (+2.25%)
AMZN   3,184.94 (-1.00%)
TSLA   422.64 (+0.17%)
NVDA   540.99 (-0.88%)
BABA   307.97 (-0.59%)
CGC   19.49 (+3.23%)
GE   7.32 (-0.27%)
MU   53.31 (-0.41%)
AMD   79.20 (-2.89%)
T   26.72 (-0.15%)
F   7.85 (+1.42%)
ACB   4.85 (+6.36%)
GILD   60.21 (-0.56%)
NFLX   489.05 (-6.92%)
BA   163.86 (-2.02%)
BAC   24.05 (-0.37%)
NIO   27.86 (-0.36%)
S&P 500   3,435.56 (-0.22%)
DOW   28,210.82 (-0.35%)
QQQ   284.19 (-0.08%)
AAPL   116.87 (-0.54%)
MSFT   214.80 (+0.07%)
FB   278.73 (+4.17%)
GOOGL   1,585.99 (+2.25%)
AMZN   3,184.94 (-1.00%)
TSLA   422.64 (+0.17%)
NVDA   540.99 (-0.88%)
BABA   307.97 (-0.59%)
CGC   19.49 (+3.23%)
GE   7.32 (-0.27%)
MU   53.31 (-0.41%)
AMD   79.20 (-2.89%)
T   26.72 (-0.15%)
F   7.85 (+1.42%)
ACB   4.85 (+6.36%)
GILD   60.21 (-0.56%)
NFLX   489.05 (-6.92%)
BA   163.86 (-2.02%)
BAC   24.05 (-0.37%)
NIO   27.86 (-0.36%)
S&P 500   3,435.56 (-0.22%)
DOW   28,210.82 (-0.35%)
QQQ   284.19 (-0.08%)
AAPL   116.87 (-0.54%)
MSFT   214.80 (+0.07%)
FB   278.73 (+4.17%)
GOOGL   1,585.99 (+2.25%)
AMZN   3,184.94 (-1.00%)
TSLA   422.64 (+0.17%)
NVDA   540.99 (-0.88%)
BABA   307.97 (-0.59%)
CGC   19.49 (+3.23%)
GE   7.32 (-0.27%)
MU   53.31 (-0.41%)
AMD   79.20 (-2.89%)
T   26.72 (-0.15%)
F   7.85 (+1.42%)
ACB   4.85 (+6.36%)
GILD   60.21 (-0.56%)
NFLX   489.05 (-6.92%)
BA   163.86 (-2.02%)
BAC   24.05 (-0.37%)
NIO   27.86 (-0.36%)
S&P 500   3,435.56 (-0.22%)
DOW   28,210.82 (-0.35%)
QQQ   284.19 (-0.08%)
AAPL   116.87 (-0.54%)
MSFT   214.80 (+0.07%)
FB   278.73 (+4.17%)
GOOGL   1,585.99 (+2.25%)
AMZN   3,184.94 (-1.00%)
TSLA   422.64 (+0.17%)
NVDA   540.99 (-0.88%)
BABA   307.97 (-0.59%)
CGC   19.49 (+3.23%)
GE   7.32 (-0.27%)
MU   53.31 (-0.41%)
AMD   79.20 (-2.89%)
T   26.72 (-0.15%)
F   7.85 (+1.42%)
ACB   4.85 (+6.36%)
GILD   60.21 (-0.56%)
NFLX   489.05 (-6.92%)
BA   163.86 (-2.02%)
BAC   24.05 (-0.37%)
NIO   27.86 (-0.36%)
Log in
NASDAQ:ACST

Acasti Pharma News Headlines

$0.20
0.00 (0.00 %)
(As of 10/21/2020 12:00 AM ET)
Add
Compare
Today's Range
$0.20
Now: $0.20
$0.20
50-Day Range
$0.19
MA: $0.21
$0.28
52-Week Range
$0.18
Now: $0.20
$3.08
Volume1.52 million shs
Average Volume3.88 million shs
Market Capitalization$19.65 million
P/E RatioN/A
Dividend YieldN/A
Beta1.89

Headlines

Acasti Pharma (NASDAQ ACST) News Headlines Today

Source:
DateHeadline
Acasti Pharma Inc. (NASDAQ:ACST) Short Interest Up 25.7% in SeptemberAcasti Pharma Inc. (NASDAQ:ACST) Short Interest Up 25.7% in September
americanbankingnews.com - October 18 at 4:16 AM
Acasti Pharma (NASDAQ:ACST) Trading Up 6.3%Acasti Pharma (NASDAQ:ACST) Trading Up 6.3%
americanbankingnews.com - October 13 at 6:54 PM
Acasti Pharma Inc. (NASDAQ:ACST) Receives Consensus Rating of "Buy" from BrokeragesAcasti Pharma Inc. (NASDAQ:ACST) Receives Consensus Rating of "Buy" from Brokerages
americanbankingnews.com - October 10 at 1:52 AM
Acasti Pharma (NASDAQ:ACST) Stock Price Up 3.4%Acasti Pharma (NASDAQ:ACST) Stock Price Up 3.4%
americanbankingnews.com - October 5 at 9:37 PM
Zacks: Brokerages Expect Acasti Pharma Inc (NASDAQ:ACST) Will Announce Earnings of -$0.07 Per ShareZacks: Brokerages Expect Acasti Pharma Inc (NASDAQ:ACST) Will Announce Earnings of -$0.07 Per Share
americanbankingnews.com - October 5 at 1:18 AM
Acasti Pharma (NASDAQ:ACST)  Shares Down 6.9% Acasti Pharma (NASDAQ:ACST) Shares Down 6.9%
americanbankingnews.com - September 30 at 8:03 PM
Acasti Pharma (NASDAQ:ACST) Shares Gap Up to $0.21Acasti Pharma (NASDAQ:ACST) Shares Gap Up to $0.21
americanbankingnews.com - September 29 at 10:39 AM
Acasti announces initiation of strategic alternative processAcasti announces initiation of strategic alternative process
seekingalpha.com - September 29 at 7:57 AM
Acasti Pharma Inc (NASDAQ:ACST) Short Interest Up 141.3% in SeptemberAcasti Pharma Inc (NASDAQ:ACST) Short Interest Up 141.3% in September
americanbankingnews.com - September 28 at 2:22 AM
New finance chief at Acasti PharmaNew finance chief at Acasti Pharma
seekingalpha.com - September 16 at 8:17 AM
Acasti Appoints Seasoned Executive Brian D. Ford CPA-CA as Chief Financial OfficerAcasti Appoints Seasoned Executive Brian D. Ford CPA-CA as Chief Financial Officer
finance.yahoo.com - September 16 at 8:17 AM
Acasti Pharma Stock Loses a Wall Street SupporterAcasti Pharma Stock Loses a Wall Street Supporter
finance.yahoo.com - September 1 at 5:04 PM
Mid-Day Market Update: Akcea Therapeutics Jumps Following Acquisition News; Acasti Pharma Shares PlummetMid-Day Market Update: Akcea Therapeutics Jumps Following Acquisition News; Acasti Pharma Shares Plummet
benzinga.com - August 31 at 1:30 PM
50 Stocks Moving In Mondays Mid-Day Session50 Stocks Moving In Monday's Mid-Day Session
msn.com - August 31 at 1:30 PM
Acasti Pharma Says Phase 3 TRILOGY 2 Study Did Not Meet Primary Endpoint - Quick FactsAcasti Pharma Says Phase 3 TRILOGY 2 Study Did Not Meet Primary Endpoint - Quick Facts
nasdaq.com - August 31 at 8:29 AM
Acasti Pharma Reports Topline Triglyceride Results from Phase 3 TRILOGY 2 Study of CaPre in Patients with Severe HypertriglyceridemiaAcasti Pharma Reports Topline Triglyceride Results from Phase 3 TRILOGY 2 Study of CaPre in Patients with Severe Hypertriglyceridemia
finance.yahoo.com - August 31 at 8:29 AM
The Week Ahead In Biotech (Aug. 30- Sept. 5): Bristol-Myers Squibb FDA Decision, Adcom Review For Glaxo, Amarin Vascepa HearingThe Week Ahead In Biotech (Aug. 30- Sept. 5): Bristol-Myers Squibb FDA Decision, Adcom Review For Glaxo, Amarin Vascepa Hearing
msn.com - August 30 at 9:35 AM
Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2021Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2021
feeds.benzinga.com - August 13 at 8:52 AM
Why Acasti Pharma's Stock Is Trading Higher TodayWhy Acasti Pharma's Stock Is Trading Higher Today
finance.yahoo.com - July 6 at 10:38 PM
Why Acasti Pharmas Stock Is Trading Higher TodayWhy Acasti Pharma's Stock Is Trading Higher Today
www.benzinga.com - July 6 at 5:38 PM
Acasti Pharma files for $200M mixed shelfAcasti Pharma files for $200M mixed shelf
seekingalpha.com - June 30 at 7:34 AM
Morning News Call - Canada, June 29Morning News Call - Canada, June 29
finance.yahoo.com - June 29 at 9:33 PM
Acasti Pharma Inc. (ACST) CEO Jan DAlvise on Q4 2020 Results - Earnings Call TranscriptAcasti Pharma Inc. (ACST) CEO Jan D'Alvise on Q4 2020 Results - Earnings Call Transcript
seekingalpha.com - June 29 at 9:33 PM
Acasti Pharma Provides Fiscal 2020 Year-End Business UpdateAcasti Pharma Provides Fiscal 2020 Year-End Business Update
www.benzinga.com - June 29 at 10:14 AM
ACST Acasti Pharma, Inc. Class A Common StockACST Acasti Pharma, Inc. Class A Common Stock
www.nasdaq.com - May 14 at 1:25 PM
Acasti Pharma Announces Submission of TRILOGY 1 Briefing Package to FDAAcasti Pharma Announces Submission of TRILOGY 1 Briefing Package to FDA
finance.yahoo.com - April 30 at 5:04 PM
Acasti Pharma Awarded Notice of Allowance for Second Composition of Matter Patent in CanadaAcasti Pharma Awarded Notice of Allowance for Second Composition of Matter Patent in Canada
finance.yahoo.com - April 20 at 1:30 PM
Acasti Pharma Submits FDA Meeting Request on Schedule, and FDA Meeting Expected in the Second Half of JuneAcasti Pharma Submits FDA Meeting Request on Schedule, and FDA Meeting Expected in the Second Half of June
finance.yahoo.com - April 1 at 5:22 PM
Acasti Pharma Awarded Notice of Allowance for Additional Composition of Matter and Method of Use Patents in the United States and MexicoAcasti Pharma Awarded Notice of Allowance for Additional Composition of Matter and Method of Use Patents in the United States and Mexico
finance.yahoo.com - March 11 at 8:32 AM
Acasti Receives NASDAQ Notification Regarding Minimum Bid RequirementsAcasti Receives NASDAQ Notification Regarding Minimum Bid Requirements
finance.yahoo.com - February 28 at 5:41 PM
Acasti Pharma Inc. (ACST) CEO Jan DAlvise on Q3 2020 Results - Earnings Call TranscriptAcasti Pharma Inc. (ACST) CEO Jan D'Alvise on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - February 14 at 8:00 PM
Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2020Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2020
finance.yahoo.com - February 14 at 8:26 AM
Acasti Pharma Schedules Third Quarter Fiscal 2020 and Business Update Conference CallAcasti Pharma Schedules Third Quarter Fiscal 2020 and Business Update Conference Call
finance.yahoo.com - February 13 at 12:03 PM
3 Beaten-Down Biotech Stocks With +50% Upside Potential3 Beaten-Down Biotech Stocks With +50% Upside Potential
finance.yahoo.com - February 11 at 12:29 PM
There’s No Miraculous Comeback Looming for Acasti Pharma StockThere’s No Miraculous Comeback Looming for Acasti Pharma Stock
investorplace.com - February 11 at 7:29 AM
Sensible Investors Will Ditch Acasti Pharma for AmarinSensible Investors Will Ditch Acasti Pharma for Amarin
www.msn.com - February 5 at 1:04 PM
Why Amarin Stock Is Poised for a Healthy 2020Why Amarin Stock Is Poised for a Healthy 2020
finance.yahoo.com - January 25 at 3:07 AM
Does Acasti Stock Have a Future?Does Acasti Stock Have a Future?
finance.yahoo.com - January 25 at 3:07 AM
Acasti Shares Slump On Failed Late-Stage Trial, Amarin Moves In SympathyAcasti Shares Slump On Failed Late-Stage Trial, Amarin Moves In Sympathy
www.msn.com - January 13 at 3:27 PM
Amarin Stock Is Surging as Rival Makers of Fish-Oil Heart Drugs Fall ShortAmarin Stock Is Surging as Rival Makers of Fish-Oil Heart Drugs Fall Short
www.barrons.com - January 13 at 3:27 PM
Amarins stock surges, as rival drugs from AstraZeneca, Acasti disappointAmarin's stock surges, as rival drugs from AstraZeneca, Acasti disappoint
www.marketwatch.com - January 13 at 3:27 PM
Amarin's stock surges, as rival drugs from AstraZeneca, Acasti disappointAmarin's stock surges, as rival drugs from AstraZeneca, Acasti disappoint
finance.yahoo.com - January 13 at 3:27 PM
Acasti Delays Data Readout For Drug To Treat Elevated TriglyceridesAcasti Delays Data Readout For Drug To Treat Elevated Triglycerides
feeds.benzinga.com - December 24 at 11:51 AM
Acasti Delays Data Readout For Drug To Treat Elevated TriglyceridesAcasti Delay's Data Readout For Drug To Treat Elevated Triglycerides
www.benzinga.com - December 24 at 10:12 AM
IIROC Trading Halt - ACSTIIROC Trading Halt - ACST
finance.yahoo.com - December 23 at 10:30 PM
Acasti Pharma Provides Update on Timing of Topline Results for TRILOGY 1 Phase 3 Trial of CaPreAcasti Pharma Provides Update on Timing of Topline Results for TRILOGY 1 Phase 3 Trial of CaPre
finance.yahoo.com - December 23 at 10:30 PM
Acasti Pharma Reports Last Patient Visit in TRILOGY 1 Phase 3 Trial of CaPre for the Treatment of Severe HypertriglyceridemiaAcasti Pharma Reports Last Patient Visit in TRILOGY 1 Phase 3 Trial of CaPre for the Treatment of Severe Hypertriglyceridemia
finance.yahoo.com - November 26 at 8:34 AM
Encode Ideas, L.P. Announces the Initiation of Research Coverage on Acasti Pharma, Inc.Encode Ideas, L.P. Announces the Initiation of Research Coverage on Acasti Pharma, Inc.
finance.yahoo.com - November 25 at 8:50 AM
Acasti Pharma - Winning The Heart RaceAcasti Pharma - Winning The Heart Race
seekingalpha.com - November 21 at 9:30 AM
Amarin's Shares Down on Underperform Rating by OppenheimerAmarin's Shares Down on Underperform Rating by Oppenheimer
finance.yahoo.com - November 21 at 9:30 AM
This page was last updated on 10/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.